- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03716336
Aerobic and Strength Training With Caloric Restriction on Insulin Resistance in Obese Premenopausal Women
October 13, 2020 updated by: Ghada Ebrahim El Refaye, Cairo University
Impact of Concurrent Aerobic and Strength Training With Caloric Restriction on Insulin Resistance in Obese Premenopausal Women: A Randomized Controlled Trial
A total of 42 premenopausal women diagnosed clinically as having insulin resistance.
Their ages ranged from 35 to 45 years old; their body mass index was >30 kg/m2 and They were obese women complained of insulin resistance and non diabetic or cardiovascular disease, were randomly assigned to group A participated in aerobic & resistive exercise program, and group B participated in aerobic exercise and followed prescribed diet restriction program.
Both of the groups (A&B) followed the treatment program 3 times per weeks for 8 weeks.
Assessment of the fasting glucose, fasting insulin, and HOMA test of insulin resistance were measured for all subjects in both groups (A and B) was carried out before and after the end of the treatment program
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Forty two obese premenopausal women diagnosed as having insulin resistance were participated in this study.
They were selected randomly from the out Patient Clinic of Obstetrics at Kasr El Ainy University Hospital, Faculty of Medicine, Cairo University.
Their age ranged from 35 - 45years, their body mass (BMI) were>30kg/m2.
Exclusion criteria of the study were as follows: Patients having diabetic or cardiovascular disease, Patients with life threatening disorders as renal failure and myocardial infarction, Patients with active malignancy and patients with severe hemorrhage, hyperthyroidism, acute viral diseases and mental disorders.
Participants were assigned randomly used sealed envelope into two groups (A&B) equally in number.
Group (A): (Combined resistive and aerobic exercise group) consisted of 20 women were participated in aerobic & resistive exercise program plus diet restriction, 3 times per weeks for 8 weeks.
Group (B): consisted of 20 women were participated in aerobic exercise plus diet restriction 3 times per weeks for 8 weeks.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Dokki
-
Giza, Dokki, Egypt, 12613
- Faculty of Physical Therapy- Cairo University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Their age ranged from 35 - 45years.
- their body mass (BMI) were>30kg/m2.
Exclusion Criteria:
- Patients having diabetic or cardiovascular disease.
- Patients with life threatening disorders as renal failure and myocardial infarction
- Patients with active malignancy.
- patients with severe hemorrhage
- hyperthyroidism.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: aerobic exercise
walking on treadmill
|
Resistance exercise were performed for all participants in group (A) only included 9 exercise for big muscles of upper limbs (shoulder flexors muscles, shoulder extensors and shoulder abductors), lower limbs (hip flexors, hip extensors and knee flexors and knee extensors) and abdominal muscle using moderate work load (60 - 75% of IRM) 1set of 10 repetitions, progressing to 2 sets of 10 repetitions after four weeks for 20 minutes
aerobic exercise were performed on treadmill.
For 20 minutes.
All patients in both groups (A,B) had attended the program of a resistance exercises and followed by aerobic exercise for 8 weeks in form of 20 minutes walking on the treadmill without inclination.
Other Names:
All participants in both groups (A,B) were instructed to follow a moderate restricted diet limited to (1800-2000) kcal/ day under supervision of a certified dietician.
The diet contained: Protein and fibers: 20% carbohydrate: 50-60%, fat: low 20%.
|
|
Other: resistive exercise
Resistance exercise were performed for all participants in group (A) included 9 exercise for big muscles of upper limbs
|
Resistance exercise were performed for all participants in group (A) only included 9 exercise for big muscles of upper limbs (shoulder flexors muscles, shoulder extensors and shoulder abductors), lower limbs (hip flexors, hip extensors and knee flexors and knee extensors) and abdominal muscle using moderate work load (60 - 75% of IRM) 1set of 10 repetitions, progressing to 2 sets of 10 repetitions after four weeks for 20 minutes
aerobic exercise were performed on treadmill.
For 20 minutes.
All patients in both groups (A,B) had attended the program of a resistance exercises and followed by aerobic exercise for 8 weeks in form of 20 minutes walking on the treadmill without inclination.
Other Names:
All participants in both groups (A,B) were instructed to follow a moderate restricted diet limited to (1800-2000) kcal/ day under supervision of a certified dietician.
The diet contained: Protein and fibers: 20% carbohydrate: 50-60%, fat: low 20%.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HOMA test of insulin
Time Frame: 8 weeks
|
A sample of 5ml of venous blood sample was drawn from the ante cubital vein after 10 hours fasting from all women in the two groups (A, B) for measurement of fasting blood glucose, fasting blood insulin and detection of insulin resistance (by HOMA-IR)
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
fasting blood insulin level
Time Frame: 8 weeks
|
A sample of 5ml of venous blood sample was drawn from the ante cubital vein after 10 hours fasting from all women in the two groups (A, B) for measurement of fasting blood insulin
|
8 weeks
|
|
fasting blood glucose level
Time Frame: 8 weeks
|
A sample of 5ml of venous blood sample was drawn from the ante cubital vein after 10 hours fasting from all women in the two groups (A, B) for measurement of fasting blood glucose
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: ghada eb elrefaye, professor, institutional review board of the Faculty of physical therapy, Cairo University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2017
Primary Completion (Actual)
May 1, 2018
Study Completion (Actual)
May 1, 2018
Study Registration Dates
First Submitted
October 21, 2018
First Submitted That Met QC Criteria
October 21, 2018
First Posted (Actual)
October 23, 2018
Study Record Updates
Last Update Posted (Actual)
October 19, 2020
Last Update Submitted That Met QC Criteria
October 13, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CairoU90
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin Resistance Syndrome
-
University Health Network, TorontoCompletedInsulin Resistance Syndrome X | Pancreatic Beta Cell FunctionCanada
-
Cairo UniversityRecruiting
-
University Hospital, GrenobleTerminatedInsulin Resistance SyndromeFrance
-
Unity Health TorontoDicofarm; University of Toronto, TorontoCompletedInsulin Resistance Syndrome
-
University Hospital, GenevaSwiss National Science FoundationCompleted
-
Hospital de BaseNot yet recruitingHypertension | Cardiovascular Risk | Arterial Stiffness | Insulin Resistance Syndrome | Blood Pressure VariabilityBrazil
-
University of Central LancashireDoNotAge.orgNot yet recruitingCardiometabolic Syndrome
-
Center of New Medical TechnologiesNovosibirsk State UniversityRecruiting
-
Assiut UniversityNot yet recruiting
-
Universiti Putra MalaysiaRecruitingMetabolic SyndromeMalaysia
Clinical Trials on Resistance exercise
-
Princess Nourah Bint Abdulrahman UniversityKırıkkale UniversityCompleted
-
Universidade Federal de PernambucoUnknownChikungunya FeverBrazil
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)TerminatedChildhood ObesityUnited States
-
National Taiwan Normal UniversityRecruitingResistance Exercise | Energy Expenditure | Energy Balance | Males and FemalesTaiwan
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI); Harvard School of Public... and other collaboratorsRecruitingCardiovascular RiskUnited States
-
University of ValenciaRecruitingRotator Cuff Related Shoulder PainSpain
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension | Healthy
-
Iowa State UniversityCompletedCardiovascular Risk Factor
-
Riphah International UniversityCompletedChronic Obstructive Pulmonary DiseasePakistan
-
University of AlbertaDexCom, Inc.CompletedType 1 DiabetesCanada